FATE1 anticorps (N-Term)
Aperçu rapide pour FATE1 anticorps (N-Term) (ABIN929375)
Antigène
Voir toutes FATE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- FATE1 antibody was raised in rabbit using the N terminal of FATE1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
FATE1 Blocking Peptide, (ABIN5613521), is also available for use as a blocking control in assays to test for specificity of this FATE1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- FATE1 (Fetal and Adult Testis Expressed 1 (FATE1))
-
Autre désignation
- FATE1
-
Sujet
- This gene encodes a cancer-testis antigen that is highly expressed in hepatocellular carcinomas and other tumors and weakly expressed in normal tissues except testis. The protein is strongly expressed in spermatogonia, primary spermatocytes, and Sertoli cells in seminiferous tubules. This protein may have a role in the control of early testicular differentiation and cell proliferation. Synonyms: Polyclonal FATE1 antibody, Anti-FATE1 antibody, fetal and adult testis expressed 1 antibody, CT43 antibody, FATE antibody.
Antigène
-